Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 1/20 | 0.80 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL9152086 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL1780251 | 1.00 | — | — | |
| Nitric Acid SCHEMBL10963059 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL5162790 | 1.00 | — | — | |
| Nitric Acid SCHEMBL14629913 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL72896 | 1.00 | — | — | |
| Nitric Acid SCHEMBL73606 | 1.00 | — | — | |
| Nitric Acid SCHEMBL5061966 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL11418180 | 0.95 | — | — | |
| Nitric Acid SCHEMBL8982116 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022212-A1 | METHODS AND COMPOSITIONS FOR THE INSTANT HYDRATON OF POLYACRYLAMIDE ARTICLES | SOLENIS TECHNOLOGIES, L.P. (US) | 2026-01-22 | — | — | US | claimed |
| CN-119161753-A | Self-excitation geopolymer anticorrosive paint and preparation method thereof | 福州大学 | 2024-12-20 | — | — | CN | claimed |
| CN-117282435-A | Hydrotalcite-like catalyst for preparing methanol by carbon dioxide hydrogenation and preparation method thereof | 浙江绿色智行科创有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-113173751-B | Phase-change gypsum and preparation method thereof | 中国科学院青海盐湖研究所 | 2023-05-26 | — | — | CN | claimed |
| CN-113173740-B | Phase-change thermal insulation mortar and preparation method thereof | 中国科学院青海盐湖研究所 | 2022-12-13 | — | — | CN | claimed |
| CN-113173739-B | Phase change concrete and preparation method thereof | 中国科学院青海盐湖研究所 | 2022-12-06 | — | — | CN | claimed |
| CN-113174157-B | Wall surface phase change putty and preparation method thereof | 中国科学院青海盐湖研究所 | 2022-04-22 | — | — | CN | claimed |
| CN-111803708-B | 3D-printed hydroxyapatite scaffold composite curcumin macromolecule/polydopamine synergistic anticancer coating and preparation method and application thereof | 华南理工大学 | 2021-11-19 | — | — | CN | claimed |
| CN-113173740-A | Phase-change thermal insulation mortar and preparation method thereof | 中国科学院青海盐湖研究所 | 2021-07-27 | — | — | CN | claimed |
| CN-113173739-A | Phase change concrete and preparation method thereof | 中国科学院青海盐湖研究所 | 2021-07-27 | — | — | CN | claimed |
| CN-113173751-A | Phase-change gypsum and preparation method thereof | 中国科学院青海盐湖研究所 | 2021-07-27 | — | — | CN | claimed |
| CN-113174157-A | Wall surface phase change putty and preparation method thereof | 中国科学院青海盐湖研究所 | 2021-07-27 | — | — | CN | claimed |
| CN-111803708-A | 3D-printed hydroxyapatite scaffold composite curcumin macromolecule/polydopamine synergistic anticancer coating and preparation method and application thereof | 华南理工大学 | 2020-10-23 | — | — | CN | claimed |
| US-20260022212-A1 | METHODS AND COMPOSITIONS FOR THE INSTANT HYDRATON OF POLYACRYLAMIDE ARTICLES | SOLENIS TECHNOLOGIES, L.P. (US) | 2026-01-22 | — | — | US | disclosed |
| EP-4566998-A1 | ALUMINA-BASED COMPOSITE OXIDE AND METHOD FOR PRODUCING ALUMINA-BASED COMPOSITE OXIDE | Daiichi Kigenso Kagaku Kogyo Co., Ltd. (JP) | 2025-06-11 | — | — | EP | disclosed |
| CN-119929851-A | Preparation method of multicomponent oxide powder | 广西大学 | 2025-05-06 | — | — | CN | disclosed |
| US-20040075386-A1 | Zinc silicate system phosphor, method for producing the same, zinc silicate system phosphor paste, and display device | KONICA CORPORATION (JP) | 2004-04-22 | — | — | US | disclosed |
| US-6500880-B1 | PH SENSITIVE ACRYLIC POLYMER OF FIRST INK WILL PRECIPITATE OR FLOCCULATE ONTO PRINT MEDIUM UPON CONTACT WITH SECOND INK WHICH CONTAINS INCOMPATIBLE INORGANIC OR ORGANIC SALTS OR HAS AN APPROPRIATE PH | HEWLETT-PACKARD COMAPNY | 2002-12-31 | — | — | US | disclosed |
| EP-1201719-A1 | Black to color bleed control using specific polymers in ink-jet printing inks containing pigmented inks requiring dispersants | Hewlett-Packard Company (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-0968986-A1 | SEMICARBAZIDE-METAL COMPLEXES AND GAS GENERATING AGENT FOR AIR BAGS | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2000-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022212-A1 | METHODS AND COMPOSITIONS FOR THE INSTANT HYDRATON OF POLYACRYLAMIDE ARTICLES | CHD9, NUP93, PML | CA5A 1384/4885CA5B 1770/4885MEN1 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.